Palmetto Targets AstraZeneca's Crestor In IP Suit
Palmetto Pharmaceuticals LLC launched a suit Tuesday in South Carolina alleging AstraZeneca Pharmaceuticals LP's blockbuster cholesterol-lowering drug Crestor infringes Palmetto's patent....To view the full article, register now.
Already a subscriber? Click here to view full article